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The antibody-forming cell response in the spleens of mice given intravenous 
sheep erythrocytes (SRBC) 1 can be monitored by use of the hemolytic plaque- 
forming cell assay (1, 2) which, if supplemented by the use of anti-mouse IgG 
"developing  serum,"  (3)  enables  the  demonstration  of  IgG plaque-forming 
cells  (indirect PFC) in addition to IgM plaque-forming cells  (direct PFC). In 
such a system the primary response to 1.5  X  l0  s SRBC is characterized by an 
initial exponential rise of direct PFC trailed at an interval of about 2 days by a 
similarly  swift  generation  of  indirect  PFC;  the  entire  detected  response  is 
aborted if  a  small  amount  of late-immune  anti-SRBC  serum  is  given a  few 
hours before the antigen. The response to a second injection of SRBC, given a 
few weeks after the primary,  differs  in several respects including an acquired 
insusceptibility  to inhibition  by anti-SRBC  serum.  This  readily  measurable 
insusceptibility  was  chosen as  a  criterion for  the  presence  of immunological 
memory. It was found that late-immune anti-SRBC  serum given too late  to 
affect the peak primary direct PFC response to SRBC remained highly potent 
in preventing both the usual subsequent indirect PFC response and the estab- 
lishment of memory. The procedure of such delayed passive immunization pro- 
vided a simple tool for dissecting a sequence of changes after primary immuniza- 
tion. 
Materials and Methods 
Animals.--Swiss white mice (Charles River Breeding Laboratories, Wilmington, Mass.), 
7-14 wk old and of both sexes, but in groups matched for age and sex within each experiment, 
were used throughout. Anti-mouse  IgG was raised in male NZW rabbits (Hazelbrook Beagles, 
London, Ontario, Canada), and complement was obtained from mature female guinea pigs 
(Canadian Breeding Farm & Laboratories Ltd., St. Constant, Quebec, Canada). 
Antigens.--Sterile  washed sheep erythrocytes were always obtained from the same male 
gelding, collected in Alsever's, and used within 1 wk of collection. Mouse IgG was separated 
* This study was supported by grant  MA-3153 from the Medical Research Council of 
Canada. 
1 Abbreviations used in this paper: direct PFC, IgM plaque-forming cells; indirect PFC, 
IgG plaque-forming cells; SRBC, sheep erythrocytes. 
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in an immunoelectrophoretically  pure form from ascitic fluid induced by Ehrlich ascites tumor 
innoculation. Initial precipitation with 50%  ammonium sulphate was followed by dialysis 
against 0.01 M phosphate buffer at pH 9 and subsequent diethylaminoethyl-cellulose  column 
chromatography with elution at pH 7.0 in 0.01 ~t phosphate. 
Sera.--Late-immune  mouse anti-SRBC serum was obtained by cardiac exsanguination of a 
pool of 200 mice given 3 )<  10 s SRBC intraperitoneally 8 and 3 wk before sacrifice. The pooled 
serum was inactivated at 56°C for 30 rain and stored frozen in small portions; it gave an SRBC 
agglutinin titer of 1/640  which was not reduced by incubation in 0.1 M 2-mercaptoethanol at 
37°C for 30 rain. Rabbit anti-mouse IgG was collected 10 wk after commencement of a course 
of two injections of purified mouse IgG in a  dose of 500 #g/kg,  the first being given with 
Freund complete adjuvant. Specificity  was tested by immunoelectrophoresis. The serum was 
inactivated at 56°C for 30 min, absorbed with SRBC, lyophilized, and stored at  --20°C as 
small samples in sealed, evacuated ampules. It was used after reconstitution at a dilution of 
1/20.  Freshly obtained guinea pig serum was lyophilized and stored at --20°C for use as com- 
plement at a dilution of 1/8 after reconstitution. 
Immunlzation.--Each  active immunization with SRBC took the form of 1.5  )<  l0  s SRBC 
intravenously. Passive immunization comprised 0.4 ml of late-immune anti-SRBC serum given 
intraperitoneally. 
Plaque-Forming Cell Assay.--This followed the method of Jerne et al.  (2) with additional 
modifications for demonstration of indirect plaque-forming cells as described by Wortis et al. 
(4). 
RESULTS 
_Passive Immunization  before Antigen Administration.--Preliminary  exl~eri- 
ments established that the pool of late-immune mouse anti-SRBC serum em- 
ployed could effectively inhibit a PFC response to sheep erythrocytes. Given 24 
hr before primary immunization, this antiserum abolished a subsequent 4 day 
response; similar administration before secondary immunization had little ef- 
fect on the PFC response which followed (Table I).  The markedly  different 
effects of such an antiserum on primary and secondary immune responses ap- 
peared to clearly distinguish "immune" from "nonimmune"  animals,  and  was 
taken as a measure of the presence of immunological memory. 
Passive Immunization  after Antigen.--If  administration of the antiserum was 
delayed for 3 days after giving antigen,  no effect on the peak primary 4  day 
direct PFC response was observed. In view of data suggesting that memory has 
not yet been established at this time (5) the possibility that such delayed passive 
immunization may yet affect memory was assessed,  by testing the secondary 
response of mice which had received anti-SRBC  serum 3  days after primary 
immunization. The results of such an experiment are included in Table I. It is 
seen here that passive immunization 3 days after first giving antigen prevents 
acquisition of the capacity for a subsequent response in the presence of antibody 
despite the fact that a peak primary direct PFC response has occurred. 
The effect of passive immunization 3 days after primary immunization was 
further characterized by comparing the later phases of the primary response of MICHAEL A.  AXELRAD 
TABLE  I 
Early and Late Passive  Immunization.  Effects  on Primary and Secondary  Responses 
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Day 
--1  0  3  4  20  21  25 
PFC/spleen*  PFC/spleen* 
--  SRBC~  --  122,650  (60,200) 
PI§  SRBC~  --  550  (0) 
--  SRBC~;  PI§  109,300  (0) 
--  SRBC~  --  PI§  SRBC~  84,400  (131,950) 
PI§  SRBC~  --  PI§  SRBC~  2,300  (0) 
--  SRBC J;  PI§  PI§  SRBC$  4,150  (0) 
* Mean group response of six to eight mice, rounded to nearest 50; direct PFC with in- 
direct PFC in parentheses. 
$1.5 X  l0  s sheep erythrocytes injected intravenously. 
§ 0.4 ml of late-immune mouse anti-SRBC serum administered intraperitoneally. 
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FI¢.  1.  The effect of passive immunization 3 days after primary active immunization on 
the primary response to 1.5  X  l0  s intravenous SRBC and the response to a  second similar 
SRBC injection which is immediately preceded by passive immunization. Each point is the 
mean response of six to eight mice. The group range is shown by dotted vertical lines for direct, 
and horizontal bars for indirect PFC. The lower graph is derived from a comparison of group 
means. Passive immunization (PI)  represents 0.4 ml of intraperitoneal late-immune mouse 
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mice  so  treated  with  that  of matched  groups  receiving  active  immunization 
alone. Levels of both direct and indirect PFC in the spleen were measured at 
various times up to 21 days after primary immunization. Two additional effects 
of passive immunization 3 days after primary immunization were seen: (a)  the 
TABLE II 
Effect  on Secondary  Response  of Passive  Immunization  at  Varying  Times  after 
Primary Active Immunization 
SRBC*  PI** 
PFC/spleen§  day 25 
Direct  Indirect 
(day)  (day) 
0 and 21  20  127,350  (83,000-152,500)  163,400  (121,000-247,500) 
0 and 21  3 and 20  9,150  (2,350-15,750)  0 
0 and 21  5 and 20  16,400  (11,300-24,100)  10,450  (5,600-14,700) 
0 and 21  7 and 20  49,300  (28,500-70,000)  61,200  (41,500-94,000) 
0 and 21  10 and 20  133,500  (78,000-164,000)  171,350  (105,000-281,000) 
* 1.5  X  10  e sheep erythrocytes injected intravenously. 
$ 0.4 ml of late-immune mouse anti-SRBC serum administered intraperitoneally. 
§ Mean group response of six mice, rounded  to nearest 50, with range in parentheses. 
TABLE III 
Effect  of Passive  Immunization  on Response  to Multiple SRBC Injections 
Day 25 
Day 0  Day 3-21  PFC/spleen* 
Direct  Indirect 
SRBC:~  PI§ +  SRBC~  38,100  (24,000-61,400)  0 
twice weekly 
SRBC~:  SRBC:~  40,800  (30,8(~48,400)  140,200  (125,800-161,400) 
twice weekly 
* Mean response of group of eight mice; range in parentheses; assay 4 days after last SRBC 
injection. 
:~ 1.5 X  108 sheep erythrocytes injected intravenously. 
§ 0.4 ml of late-immune mouse anti-SRBC serum administered intraperitoneally starting 
on day 3, each followed in 24 hr by SRBC. 
procedure  prevented  the  appearance  of  the  indirect  PFC  component  of  the 
primary response, (b) it resulted in a more rapid decline of the peak direct PFC 
response  (Fig.  1). 
Passive immunization 3  days after primary immunization prevented aquisi- 
tion of the capacity for a subsequent response in the presence of antibody. It was 
tested to what extent such an effect was demonstrable when passive immuniza- 
tion was further delayed. The results shown in Table II indicate a  decreasing MICHAEL  A.  AXELRAD  861 
effect which is still demonstrable after a delay of as much as 7 days. Thus pas- 
sive immunization given after the appearance and even after the peak of the 
primary indirect PFC response (Fig. 1) can still affect the development of the 
capacity for a subsequent response in the presence of antibody. 
Finally, the response to a  course of twice weekly injections of SRBC,  each 
given 24 hr after anti-SRBC serum, and begun 4 days after primary immuniza-- 
tion, was measured. 
In these circumstances a level of direct PFC response similar to that of mice 
receiving equivalent active immunization only was present after 25 days (Ta- 
ble III). The mice receiving passive immunization had not however generated 
any indirect PFC by this time, indicating that escape from antibody inhibition 
was possible in the absence of an indirect PFC response. 
DISCUSSION 
It is recognized that primary and secondary responses may have apparent 
distinguishing features contributed to by differences in the composition of the 
cellular populations available for the response to antigen (6). Distinctions be- 
tween primary and secondary responses are sometimes muddied but can often 
be drawn with respect to parameters such as rapidity, magnitude and antigen 
sensitivity, class and combining affinity of immunoglobulin produced, sequence 
of immunoglobulin production, effect of adjuvants, and susceptibility to a vari- 
ety of suppressants  including antibody to the antigen,  anti-lymphocyte anti- 
body, and X-irradiation (7-18). The ability to mount a secondary response may 
be ascribed to immunological memory. Data previously presented concerning 
the response to SRBC is in keeping with the view that immunization results in 
two types of memory. The first is based on augmentation of the original system 
for response, is present from a very early time after immunization, and is well 
demonstrated when the response of immune cells is  looked for after transfer 
into a milieu free of antibody to SRBC. The second appears later and is neces- 
sary for the normal secondary response in vivo. It is presumably dependent on 
a change occurring in the composition of the cell populations available for re- 
sponse to antigen, one effect of which is a different type of in vitro response be- 
coming apparent about  10 days after in vivo immunization  (5). The experi- 
ments presently reported further examine this second form of immunological 
memory. In the system used a single, easily ascertainable feature, the appear- 
ance of a  response which  is  not  dramatically suppressed by the presence of 
antibody to the antigen,  is chosen to indicate the presence of such memory. 
It was found that passive immunization, with late-immune anti-SRBC serum 
on the 3rd day of the primary response to 1.5 X  10  s SRBC, did not depress the 
subsequent peak direct PFC response but prevented establishment of memory. 
A concomitant effect was the abolition of the primary indirect PFC  response. 
These results suggested two questions: (a) was the abolition of the indirect PFC 862  SUPPRESSION  OF  MEMORY  BY  ANTIBODY 
response effected by preventing transformation of direct PFC to indirect PFC 
or by suppression of a separate group of responding cells and (b) is the appear- 
ance  of indirect PFC  synonymous with  the  establishment  of immunological 
memory. 
With respect to the first question, such data as we presently have suggests 
that the normal decline of direct PFC is not due to their transformation into 
indirect PFC. Thus,  (a)  the decline in splenic direct PFC is accelerated when 
appearance  of indirect PFC  is  prevented by late passive immunization;  (b) 
spleen cell cultures set up at the time transformation should be occurring failed 
to yield detectable numbers of indirect PFC (5) ; (c) the in vitro response of cells 
from passively immunized animals suggests that antibody does not suppress the 
direct PFC response by incorporation into or on cells  (5). If so, at the time of 
delayed passive  immunization  the  affected process  is  probably  still  one de- 
pendent on stimulation by extraceltular antigen rather than one triggered in an 
earlier phase of the primary response. 
With respect to the second question, the appearance of indirect PFC was not 
synonymous with the establishment of memory. The capacity for a subsequent 
response in the presence of anti-SRBC antibody was still significantly crippled 
when passive immunization was delayed until the time of the peak primary in- 
direct PFC response. Again, mice given passive immunization on day 3 of the 
primary response and further combined active and passive immunization twice 
weekly starting on day 4, generated by day 25 similar numbers of splenic direct 
PFC  as  mice receiving identical active immunization but no  antibody.  The 
passively immunized mice had not, however, produced detectable indirect PFC. 
Under the conditions of this experiment, mice which had not had indirect PFC 
responses evidenced postprimary direct PFC responses of the same magnitude 
as those shown by mice which had produced indirect PFC responses. 
SUM-MARY 
The acquisition of a  capacity to respond well to sheep erythrocytes in the 
presence of anti-SRBC antibody was taken as an indication of the presence of 
immunological memory. By the use of passive immunization, both the primary 
IgG  plaque-forming  cell  response  and  the  establishment  of  memory  were 
abolished,  despite occurrence of a full peak IgM PFC response. Evidence for 
regarding the aquisition of memory and the IgM PFC and IgG PFC responses 
as three separate processes was presented. Antibody on day 3 of the response to 
1.5  X  10  s SRBC abolished formation of memory; this effect was less if passive 
immunization was further delayed and absent by day 10. 
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